These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Percutaneous penetration of topically applied melatonin in a cream and an alcoholic solution. Fischer TW; Greif C; Fluhr JW; Wigger-Alberti W; Elsner P Skin Pharmacol Physiol; 2004; 17(4):190-4. PubMed ID: 15258450 [TBL] [Abstract][Full Text] [Related]
23. The transdermal drug delivery system and transcutaneous absorption. Morimoto Y; Sugibayashi K; Natsume H Acta Derm Venereol Suppl (Stockh); 1994; 185():15-7. PubMed ID: 8091920 [No Abstract] [Full Text] [Related]
24. Effective use of emollients in infants and young people. Lawton S Nurs Stand; 2004 Oct 27-Nov 2; 19(7):44-50; quiz 52, 54. PubMed ID: 15551917 [TBL] [Abstract][Full Text] [Related]
25. Bioassay system for formulations of topically applied glucocorticosteroids. Stoughton RB Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246 [No Abstract] [Full Text] [Related]
27. In vitro percutaneous absorption of ketoprofen and testosterone: comparison of pluronic lecithin organogel vs. pentravan cream. Lehman PA; Raney SG Int J Pharm Compd; 2012; 16(3):248-52. PubMed ID: 23050302 [TBL] [Abstract][Full Text] [Related]
28. Enhanced skin permeability for transdermal drug delivery: physiopathological and physicochemical considerations. Xu P; Chien YW Crit Rev Ther Drug Carrier Syst; 1991; 8(3):211-36. PubMed ID: 1954651 [TBL] [Abstract][Full Text] [Related]
29. Cushing syndrome from percutaneous absorption of 1% hydrocortisone ointment in Netherton syndrome. Halverstam CP; Vachharajani A; Mallory SB Pediatr Dermatol; 2007; 24(1):42-5. PubMed ID: 17300648 [TBL] [Abstract][Full Text] [Related]
30. [Local applications of corticosteroids in dermatology]. Naĭdenov IuN Voen Med Zh; 1983 Jul; (7):63-4. PubMed ID: 6623961 [No Abstract] [Full Text] [Related]
31. Percutaneous absorption of topically applied triamcinolone in children. Rasmussen JE Arch Dermatol; 1978 Aug; 114(8):1165-7. PubMed ID: 677913 [TBL] [Abstract][Full Text] [Related]
32. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease. Olson KA; West K; McCarthy PL Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567 [TBL] [Abstract][Full Text] [Related]
33. [Some data on external therapy of dermatoses]. Ormea TF Minerva Med; 1973 Oct; 64(77):4021-8. PubMed ID: 4764073 [No Abstract] [Full Text] [Related]
34. Percutaneous absorption and the surface area of occluded skin. A scanning electron microscopic study. Harris DR; Papa CM; Stanton R Br J Dermatol; 1974 Jul; 91(1):27-32. PubMed ID: 4853573 [No Abstract] [Full Text] [Related]
35. Gel ointment of verapamil for percutaneous absorption. Sekine T; Machida Y; Nagai T Drug Des Deliv; 1987 Feb; 1(3):245-52. PubMed ID: 3509338 [TBL] [Abstract][Full Text] [Related]
36. Topical corticosteroids for skin disorders in infants and children. Keipert JA Aust Fam Physician; 1985 May; 14(5):392-7. PubMed ID: 3160326 [No Abstract] [Full Text] [Related]
37. [Transdermal therapeutic methods]. Aiache JM Ann Cardiol Angeiol (Paris); 1997; 46(7):441-9. PubMed ID: 9452779 [TBL] [Abstract][Full Text] [Related]
38. Modest but increased penetration through damaged skin: an overview of the in vivo human model. Gattu S; Maibach HI Skin Pharmacol Physiol; 2011; 24(1):2-9. PubMed ID: 20588085 [TBL] [Abstract][Full Text] [Related]
39. Transdermal patches: past, present and future. Miller K Ther Deliv; 2015; 6(6):639-41. PubMed ID: 26149780 [No Abstract] [Full Text] [Related]